Format

Send to

Choose Destination
Diabetes Res Clin Pract. 2006 Sep;73(3):298-303. Epub 2006 Apr 3.

Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study.

Author information

1
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia. Robyn.Tapp@med.monash.edu.au

Abstract

AIMS:

To determine the incidence, progression and risk factors for diabetic retinopathy in the multiethnic population of Mauritius.

METHOD:

A longitudinal, population-based study was conducted in Mauritius, during 1987, 1992 and 1998. Participants identified through the study as having diabetes (both known and newly diagnosed, by self-report and oral glucose tolerance test) and one in four participants with impaired glucose tolerance (IGT) underwent complications screening in 1992 and 1998. Retinal photographs were taken using a TRC-50VT retinal camera in three fields of the right eye (centred on the optic disc; macula (temporal to the optic disc); and nasal to disc). Photographs were graded according to a simplified version of the Wisconsin grading system.

RESULTS:

The 6-year incidence of diabetic retinopathy was 23.8% (sight-threatening in 0.4%). Among those with known diabetes mellitus (KDM) and free of retinopathy at baseline the incidence of non-proliferative diabetic retinopathy (NPDR) was 29.2% and proliferative diabetic retinopathy (PDR) was 1.0%. Among those with newly diagnosed diabetes mellitus (NDM) at baseline the incidence of NPDR was 19.1% (no incident cases of PDR were found). Independent risk factors for retinopathy using the baseline population characteristics were duration of diabetes and fasting plasma glucose.

CONCLUSIONS:

This is one of the few recent population-based studies of diabetic retinopathy undertaken in a developing nation. The incidence of retinopathy in Mauritius was high among those with NDM at baseline, with one in five developing retinopathy over 6 years. These results support the concept that screening for diabetes is important.

PMID:
16584802
DOI:
10.1016/j.diabres.2006.02.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center